Metlife Inc (MET) Shares Bought by Rothschild Investment Corp IL

Rothschild Investment Corp IL raised its holdings in Metlife Inc (NYSE:MET) by 2.9% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 81,678 shares of the financial services provider’s stock after purchasing an additional 2,317 shares during the quarter. Rothschild Investment Corp IL’s holdings in Metlife were worth $3,816,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Independence Bank of Kentucky raised its position in shares of Metlife by 22.2% during the third quarter. Independence Bank of Kentucky now owns 12,354 shares of the financial services provider’s stock worth $577,000 after acquiring an additional 2,243 shares during the last quarter. MERIAN GLOBAL INVESTORS UK Ltd raised its position in shares of Metlife by 17.4% during the third quarter. MERIAN GLOBAL INVESTORS UK Ltd now owns 75,686 shares of the financial services provider’s stock worth $3,536,000 after acquiring an additional 11,209 shares during the last quarter. Verity & Verity LLC raised its position in shares of Metlife by 12.7% during the third quarter. Verity & Verity LLC now owns 66,744 shares of the financial services provider’s stock worth $3,118,000 after acquiring an additional 7,519 shares during the last quarter. Ronna Sue Cohen raised its position in shares of Metlife by 5.4% during the third quarter. Ronna Sue Cohen now owns 65,857 shares of the financial services provider’s stock worth $3,077,000 after acquiring an additional 3,375 shares during the last quarter. Finally, Nisa Investment Advisors LLC raised its position in shares of Metlife by 2.2% during the third quarter. Nisa Investment Advisors LLC now owns 313,135 shares of the financial services provider’s stock worth $14,630,000 after acquiring an additional 6,769 shares during the last quarter. Hedge funds and other institutional investors own 77.47% of the company’s stock.

In other Metlife news, Chairman Steven A. Kandarian sold 42,805 shares of the business’s stock in a transaction dated Monday, August 27th. The stock was sold at an average price of $47.03, for a total value of $2,013,119.15. Following the completion of the transaction, the chairman now directly owns 559,097 shares of the company’s stock, valued at $26,294,331.91. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Chairman Steven A. Kandarian sold 85,683 shares of the company’s stock in a transaction dated Tuesday, August 21st. The stock was sold at an average price of $46.93, for a total value of $4,021,103.19. Following the transaction, the chairman now directly owns 585,005 shares of the company’s stock, valued at $27,454,284.65. The disclosure for this sale can be found here. Corporate insiders own 0.34% of the company’s stock.

NYSE MET traded up $0.81 on Wednesday, reaching $44.66. The company had a trading volume of 570,089 shares, compared to its average volume of 5,973,705. The company has a market capitalization of $46.48 billion, a PE ratio of 9.94, a P/E/G ratio of 0.71 and a beta of 1.23. The company has a current ratio of 0.15, a quick ratio of 0.15 and a debt-to-equity ratio of 0.29. Metlife Inc has a 52 week low of $42.80 and a 52 week high of $55.91.

Metlife (NYSE:MET) last released its quarterly earnings data on Wednesday, August 1st. The financial services provider reported $1.30 EPS for the quarter, beating analysts’ consensus estimates of $1.17 by $0.13. The business had revenue of $21.22 billion during the quarter, compared to the consensus estimate of $15.65 billion. Metlife had a return on equity of 9.17% and a net margin of 6.12%. The firm’s revenue was up 36.8% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.04 earnings per share. As a group, sell-side analysts predict that Metlife Inc will post 5.22 earnings per share for the current fiscal year.

A number of equities research analysts have recently weighed in on MET shares. Zacks Investment Research downgraded Metlife from a “buy” rating to a “hold” rating in a research report on Thursday, August 9th. UBS Group boosted their target price on Metlife from $48.00 to $49.00 and gave the stock a “neutral” rating in a research report on Monday, October 8th. Barclays dropped their target price on Metlife from $60.00 to $57.00 and set an “overweight” rating for the company in a research report on Monday, July 9th. Sandler O’Neill restated a “hold” rating and set a $50.00 target price on shares of Metlife in a research report on Thursday, August 2nd. Finally, Wells Fargo & Co restated a “buy” rating and set a $60.00 target price on shares of Metlife in a research report on Thursday, September 27th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and seven have given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus target price of $55.00.

Metlife Company Profile

MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.

See Also: Tariff

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Metlife Inc (NYSE:MET).

Institutional Ownership by Quarter for Metlife (NYSE:MET)

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply